ClinicalTrials.gg

Drug class

Hydroxymethylglutaryl-CoA Reductase Inhibitors clinical trials

A class of medicines: the studies that test any of its 10 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
1,715
open now
139
in phase 3
351
first study started
1990

Keep track of what changes. Save the hydroxymethylglutaryl-coa reductase inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Amlodipine, atorvastatin drug combination
4
Ppd-10558
1

Studies by the year they started

1,699 studies that test it; most in 2007 (96); 1 more planned to start later

Studies that test Hydroxymethylglutaryl-CoA Reductase Inhibitors, by start year
YearStudies
19901
19911
19931
19961
19971
19988
19993
200015
200114
200232
200355
200458
200592
200687
200796
200893
200978
201088
201174
201276
201367
201482
201586
201659
201758
201846
201951
202068
202159
202247
202351
202454
202550
202647

By phase

A phase 1/2 study counts in both.

Early Phase 1
35
Phase 1
398
Phase 2
372
Phase 3
351
Phase 4
447
No phase
189

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 594 · Other 1,121

AstraZeneca (79) · Organon and Co (52) · Pfizer (34) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (31) · Merck Sharp & Dohme LLC (22) · Samsung Medical Center (19) · Yonsei University (19) · Chong Kun Dang Pharmaceutical (17)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 1,715

See all 1,715 studies that test one of the hydroxymethylglutaryl-coa reductase inhibitors →